摘要
多西他赛是卵巢癌患者术后常用化疗药物之一,但在用药过程中应注意,一旦发生药物外渗势必对患者局部皮肤造成负面影响。本文回顾性分析本院收治的1例卵巢癌术后化疗期间因拒绝接受PICC且出现多西他赛外渗患者的临床资料,分析卵巢癌患者术后发生多西他赛外渗的原因及处理对策,以期为今后临床医务人员采取有效措施降低多西他赛外渗风险、在处理多西他赛外渗患者时能够积极采取有效对策提供可靠参考。
Docetaxel is one of the commonly used chemotherapy drugs for postoperative ovarian cancer patients,but attention should be paid during the medication process.Once the drug extravasates,it will inevitably have a corresponding negative impact on the patient's local skin.This article retrospectively analyzes the clinical data of a patient with ovarian cancer who refused to receive PICC and experienced docetaxel extravasation during postoperative chemotherapy in our hospital.We analyze the causes and management strategies of docetaxel extravasation in ovarian cancer patients after surgery,in order to provide reliable reference for clinical medical staff to take effective measures to reduce the risk of docetaxel extravasation and actively take effective measures when dealing with docetaxel extravasation patients in the future.
作者
康筱珊
Kang Xiaoshan(Department of Gynecology,Lanzhou Maternal and Child Health Hospital,Lanzhou 730000,China)
出处
《实用妇科内分泌电子杂志》
2024年第15期126-128,共3页
Electronic Journal of Practical Gynecological Endocrinology
关键词
多西他赛
卵巢癌
如意金黄散
Docetaxel
Ovarian cancer
Ruyi Jinhuang San
